Skip to main content
. Author manuscript; available in PMC: 2016 Apr 28.
Published in final edited form as: AJR Am J Roentgenol. 2015 Nov;205(5):1026–1037. doi: 10.2214/AJR.14.14185

TABLE 2.

Patient and Dose Information for the 25 Abdominopelvic and 25 Chest CT Examinations Evaluated

CT Examination, Contrast Agent Status, Kilovoltage No. of Patients Age (y)
CTDIvol (mGy), Mean ± SD SSDE (mGy), Mean ± SD
Mean ± SD Range

Abdominopelvic
 With contrast agent
  80 kV 0 NA NA NA NA
  100 kV 11 8.4 ± 5.8 1–17 5.2 ± 2.5 9.1 ± 3.3
  120 kV 13 9.6 ± 4.1 4–16 7.4 ± 5.6 11.1 ± 4.5
 Without contrast agent, 120 kV 1 8.0 ± 0.0 8–8 4.0 ± 0.0 7.4 ± 0.0

 Total 25 8.7 ± 4.8 1–17 6.4 ± 4.3 10.3 ± 3.8

Chest
 With contrast agent
  80 kV 1 0.0 ± 0.0 0–0 1.1 ± 0.0 2.6 ± 0.0
  100 kV 8 2.0 ± 0.7 1–3 2.1 ± 0.6 4.5 ± 1.3
  120 kV 4 7.2 ± 2.3 6–11 2.8 ± 0.7 5.1 ± 1.3
 Without contrast agent, 120 kV 11 6.8 ± 5.7 1–17 2.6 ± 1.5 4.5 ± 1.8

 Total 25 5.1 ± 4.7 0–17 2.4 ± 1.1 4.5 ± 1.5

Note—The volume CT dose index (CTDIvol) was based on a 32-cm CT dose index (CTDI) phantom. SSDE = size-specific dose estimate, NA = not applicable.